Enterprise Therapeutics Limited

United Kingdom

Create a watch for Enterprise Therapeutics Limited
Total IP 18
Total IP Rank # 84,706
IP Activity Score 1.8/5.0    9
IP Activity Rank # 101,934

Patents

Trademarks

6 0
1 0
11 0
0
 
Last Patent 2024 - Substituted benzodiazoliums as e...
First Patent 2017 - Compounds

Latest Inventions, Goods, Services

2023 Invention Substituted benzodiazoliums as enac inhibitors. 5 and X are as defined herein are inhibitors of t...
2020 Invention Compounds. Compounds of general formula (I): Compounds of general formula (I): Compounds...
Invention Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions. Co...
Invention Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phneyl)acetyl]amino]pyridine-2-carboxamide. ...
Invention Pyridine derivatives as calcium-activated chloride channel modulators. Compounds of general formu...
Invention Solid forms of 4-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-n-(1,1-dimethylprop-2-ynyl)pyridine...
Invention Crystalline form of 4-[[2-(5-chloro-2-hydroxy-phenyl)acetyl]amino]-n-cyclohexyl-pyridine-2-carbox...
Invention Compounds for treating respiratory disease. Compounds of general formula (I) and their tautomeric...
2019 Invention Compounds with activity as inhibitors of the epithelial sodium channel (enac). 4 and X are as def...
Invention Compounds. Compounds of general formula (I) wherein R1, R2, R3, R4 and X are as defined herein ar...
Invention Compounds. Compounds of general formula (I): wherein R1, R2, R3, R4, R5a, R5bX1, X2, Z and Y are ...
2018 Invention Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1h-1,3-benzod...
2017 Invention Benzodiazolium compounds as enac inhibitors. Compounds of general formula (I) wherein R1, R2, R3,...
Invention Compounds. − are as defined herein. The compounds are inhibitors of the epithelial sodium channel...
Invention Compounds. The invention relates to compounds of general formula (I): wherein R1, R2, R3, R10 and...